Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations

Transplantation

Volumn 70, Issue 2, 2000, Pages 327-335

  Kung, Lina ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOSPORIN; CYCLOSPORIN A; FK 506 BINDING PROTEIN; IMMUNOPHILIN; TACROLIMUS;

ANIMAL CELL; ARTICLE; COMPLEMENT INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENCY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0034721108     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200007270-00017     Document Type: Article

References (39)

1. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807.
2. Zhu D, Cardenas ME, Heitman J Calcineurin mutants render T lymphocytes resistant to cyclosporin A. Mol Pharmacol 1996; 50: 506.
3. Clipstone NA, Crabtree GR. Identification of Calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992; 357: 695.
4. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 1992; 89: 3686.
5. Liu J, Albers MW, Wandless TJ, et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of Calcineurin phosphatase activity. Biochemistry 1992; 31: 3896.
6. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992; 13: 136.
7. Shaw KTY, Ho AM, Raghavan A, et al. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci USA 1995; 92: 11205.
8. McCaffrey PG, Perrino BA, Soderling TR, Rao A. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem 1993; 268: 3747.
9. Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann NY Acad Sci 1993; 696: 9.
10. Griffith JP, Kim JL, Kim EE, et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 1995; 82: 507.
11. Kissinger CR, Parge HE, Knighton DR, et al. Crystal structure of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 1995; 378: 641.
12. Husi H, Luyten MA, Zurini MGM. Mapping of the immunophilin-immunosuppressant site of interaction on calcineurin. J Biol Chem 1994; 269: 14199.
13. Garcia-Cozar FJ, Okamura H, Aramburu JF, et al. Two-site interaction of nuclear factor of activated T cells with activated calcineurin. J Biol Chem 1998; 273: 23877.
14. Kawamura A, Su MSS. Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain. J Biol Chem 1995; 270: 15463.
15. Milan D, Griffith J, Su M, Price ER, McKeon F. The latch region of calcineurin B is involved in both immunosuppressantimmunophilin complex docking and phosphatase activation. Cell 1994; 79: 437.
16. Cardenas ME, Muir RS, Breuder T, Heitman J. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J 1995; 14: 2772.
17. Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J.Immunol 1987; 139: 1797.
18. Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 1987; 40: 1249.
19. Manez R, Jain A, Marino IR, Thomson AW. Comparative evaluation of tacrolimus (FK506) and cyclosporin A as immunosuppressive targets. Transplant Rev 1995; 9: 63.
20. Soldin SJ. Receptor (immunophilin-binding) assay for immunosuppressive drugs. Ther Drug Monit 1995; 17: 574.
21. Batiuk TD, Kung L, Halloran PF. Evidence that calcineurin is rate-limiting for primary human lymphocyte activation. J Clin Invest 1997; 100: 1894.
22. Wang DZ, McCaffrey PG, Rao A. The cyclosporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system. Ann NY Acad Sci 1995; 766: 182.
23. Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Rischer PA, Sigal NH. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol 1990; 144: 1418.
24. Marks AR. Cellular functions of immunophilins. Physiol Rev 1996; 76: 631.
25. Galat A. Peptidylproline cis-trans-isomerases: immunophilins. Eur J Biochem 1993; 216: 689.
26. Bram RJ, Hung DT, Martin PK, Schreiber SL, Crabtree GR. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 1993; 13: 4760.
27. Sewell TJ, Lam E, Martin MM, et al. Inhibition of calcineurin by a novel FK-506-binding protein. J Biol Chem 1994; 269: 21094.
28. Baughman G, Wiederrecht GJ, Chang F, Martin MM, Bourgeois S. Tissue distribution and abundance of human FKBP51, an FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun 1997; 232: 437.
29. Nigam SK, Jin Y-J, Jin M-J, Bush KT, Bierer BE, Burakoff SJ. Localization of the FK506-binding protein, FKBP 13, to the lumen of the endoplasmic reticulum. Biochem J 1993; 294: 511.
30. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278: 2075.
31. Coghlan VM, Perrino BA, Howard M, et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995; 267: 108.
32. 2+ flux. Cell 1995; 83: 463.
33. Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997; 386: 728.
34. Wang T, Donahoe PK, Zervos AS. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 1994; 265: 674.
35. Okadome T, Oeda E, Saitoh M, et al. Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo. J Biol Chem 1996; 271: 21687.
36. Alexander DR, Hexham JM, Crumpton MJ. The association of type 1, type 2A and type 2B phosphatases with the human T lymphocyte plasma membrane. Biochem J 1988; 256: 885.
37. Kennedy MT, Brockman H, Rusnak F. Determinants of calcineurin binding to model membranes. Biochemistry 1997; 36: 13579.
38. Sun L, Youn H-D, Loh C, Stolow M, He W, Liu JO. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 1998; 8: 703.
39. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH. Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 1998; 273: 18325.